TrialClinical drug investigation2021

Impact of Daridorexant, a Dual Orexin Receptor Antagonist, on Cardiac Repolarization Following Bedtime Dosing: Results from a Thorough QT Study Using Concentration-QT Analysis.

Uta Schilling et al.PubMed ↗Publisher ↗

No numbers read from the abstract.